Charles Schwab’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,508,377
Closed -$3.11M 3627
2022
Q4
$3.11M Buy
3,508,377
+674,716
+24% +$895K ﹤0.01% 2422
2022
Q3
$4.45M Buy
2,833,661
+66,757
+2% +$151K ﹤0.01% 2269
2022
Q2
$5.56M Buy
2,766,904
+565,217
+26% +$977K ﹤0.01% 2142
2022
Q1
$5.13M Buy
2,201,687
+58,593
+3% +$183K ﹤0.01% 2267
2021
Q4
$9.97M Buy
2,143,094
+110,344
+5% +$685K ﹤0.01% 2008
2021
Q3
$15.5M Buy
2,032,750
+302,190
+17% +$2.56M 0.01% 1765
2021
Q2
$16.8M Buy
1,730,560
+91,306
+6% +$727K 0.01% 1709
2021
Q1
$13.6M Buy
1,639,254
+116,705
+8% +$1.23M 0.01% 1782
2020
Q4
$10.4M Buy
1,522,549
+152,480
+11% +$1.22M ﹤0.01% 1851
2020
Q3
$15.3M Buy
1,370,069
+927,446
+210% +$8.49M 0.01% 1395
2020
Q2
$2.78M Buy
442,623
+117,131
+36% +$448K ﹤0.01% 2299
2020
Q1
$599K Buy
325,492
+8,463
+3% +$24.4K ﹤0.01% 2653
2019
Q4
$1.07M Buy
317,029
+23,894
+8% +$57K ﹤0.01% 2575
2019
Q3
$628K Buy
293,135
+18,689
+7% +$43.6K ﹤0.01% 2715
2019
Q2
$733K Buy
274,446
+40,192
+17% +$145K ﹤0.01% 2679
2019
Q1
$1.11M Sell
234,254
-38,411
-14% -$101K ﹤0.01% 2521
2018
Q4
$655K Buy
272,665
+35,590
+15% +$116K ﹤0.01% 2669
2018
Q3
$1.04M Buy
237,075
+57,136
+32% +$317K ﹤0.01% 2612
2018
Q2
$1.3M Buy
179,939
+162,000
+903% +$1.1M ﹤0.01% 2506
2018
Q1
$93K Buy
+17,939
New +$128K ﹤0.01% 3046
2017
Q2
Sell
-39,855
Closed -$158K 3157
2017
Q1
$158K Hold
39,855
﹤0.01% 2964
2016
Q4
$196K Hold
39,855
﹤0.01% 2967
2016
Q3
$309K Hold
39,855
﹤0.01% 2785
2016
Q2
$224K Hold
39,855
﹤0.01% 2895
2016
Q1
$215K Hold
39,855
﹤0.01% 2880
2015
Q4
$348K Hold
39,855
﹤0.01% 2804
2015
Q3
$335K Sell
39,855
-1,100
-3% -$17.5K ﹤0.01% 2781
2015
Q2
$722K Buy
+40,955
New +$526K ﹤0.01% 2548

Other funds holding SRNE